Combination therapy with pulsed methylprednisolone in rheumatoid arthritis.
Pulsed methylprednisolone (PMP) has been shown to produce clinical improvement and reduction in the ESR and acute phase protein concentrations in patients with active rheumatoid arthritis and has been advocated for use either as an alternative to slow-acting antirheumatoid drugs (SAARDs) or in conju...
Guardado en:
| Publicado en: | Ann Rheum Dis |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
1985
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001764/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2865930/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.44.11.747 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
